Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Consensus document on frailty: conceptualization, detection, multidisciplinary management and future roadmap

  • Álvarez-Bustos, Alejandro
  • Andrés-Lacueva, Cristina
  • Ara, Ignacio
  • Arévalo, María Ángeles
  • Bolaños, Juan P.
  • Coto, Ana
  • Enríquez, José Antonio
  • Escames, Germaine
  • García-García, Francisco José
  • Gómez-Cabrera, Mari Carmen
  • Grau, Oriol
  • Izquierdo, Mikel
  • Martínez Velilla, Nicolás
  • Matheu, Ander
  • Menéndez Colino, Rocío
  • Muñoz Torres, Manuel
  • Nogués, Xavier
  • Oliva, Juan
  • Orts-Cortés, María Isabel
  • Párraga Martínez, Ignacio
  • Priego, Feliciano
  • Rabassa, Montserrat
  • Rol, María Ángeles
  • Serra-Rexach, José Antonio
  • Tarazona-Santabalbina, Francisco José
  • Rodríguez-Mañas, Leocadio
  • Abizanda, Pedro
The lack of a universally accepted definition, a gold-standard assessment tool, and sufficient evidence-based interventions has hindered the integration of frailty into routine clinical practice, particularly outside geriatric medicine. For clinicians, health professionals, policymakers, and aging researchers, a unified framework based on robust evidence has become essential., The present study received funding from the projects CB16/10/00408, CB16/10/00269, CB16/10/00477, CB16/10/00383, CB16/10/00282, CB16/10/00289, CB16/10/00238, CB16/10/00456, CB16/10/00435, CB16/10/00417, CB16/10/00315, CB16/10/00496, CB16/10/00468, CB16/10/00475, CB16/10/00245, CB23/10/00037, CB16/10/00501, CB16/10/00464, CB16/10/00239, CB16/10/00314, Instituto de Salud Carlos III, Madrid, Spain., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Glucose 6 phosphate dehydrogenase overexpression rescues the loss of cognition in the double transgenic APP/PS1 mouse model of Alzheimer’s disease

  • Correas, Ángela G.
  • Olaso-Gonzalez, Gloria
  • Roca, Marta
  • Blanco-Gandía, Mari Carmen
  • Nascimento, Carla
  • Lahoz, Agustín
  • Rodríguez-Arias, Marta
  • Miñarro, José
  • Gómez-Cabrera, Mari Carmen
  • Viña, José
Mice models of Alzheimer's disease (APP/PS1) typically experience cognitive decline with age. G6PD overexpressing mice (G6PD-Tg) exhibit better protection from age-associated functional decline including improvements in metabolic and muscle functions as well as reduced frailty compared to their wild-type counterparts. Importantly G6PD-Tg mice show diminished accumulation of DNA oxidation in the brain at different ages in both males and females. To further explore the potential benefits of modulating the G6PD activity in neurodegenerative diseases, triple transgenic mice (3xTg G6PD) were generated, overexpressing APP, PSEN1, and G6PD genes. The cognitive decline characteristic of APP/PS1 mice was prevented in 3xTg G6PD mice, despite similar amyloid-β (Aβ) levels in the hippocampus. This challenges the dominant hypothesis in Alzheimer's disease (AD) etiology and the majority of therapeutic efforts in the field, based on the notion that Aβ is pivotal in cognitive preservation. Notably, the antioxidant properties of G6PD led to a decrease in oxidative stress parameters, such as improved GSH/GSSG and GSH/CysSSG ratios, without major changes in oxidative damage markers. Additionally, metabolic changes in 3xTg G6PD mice increased brain energy status, countering the hypometabolism observed in Alzheimer's models. Remarkably, a higher respiratory exchange ratio suggested increased carbohydrate utilization. The relative failures of Aβ-targeted clinical trials have raised significant skepticism on the amyloid cascade hypothesis and whether the development of Alzheimer's drugs has followed the correct path. Our findings highlight the significance of targeting glucose-metabolizing enzymes rather than solely focusing on Aβ in Alzheimer's research, advocating for a deeper exploration of glucose metabolism's role in cognitive preservation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Exercise as a Therapy for Successful Aging

  • Ara, Ignacio
  • Gómez-Cabrera, María Carmen
  • Garatachea, Nuria
Regular physical activity has profound and multifaceted benefits for individuals as they age. This review highlights the role of exercise in promoting healthy and successful aging, emphasizing its effectiveness in the prevention and treatment of frailty and disability. Exercise is a primary intervention to attenuate the age‐related biological and functional decline by targeting mainly the cardiorespiratory, vascular, nervous, and skeletal muscle systems. From a biological perspective, we review the evidence on the role of exercise in mitigating the three categories of the biological hallmarks of aging: primary, antagonistic, and integrative. Different types of exercise may elicit different benefits for older adults. Thus, our review also emphasizes the importance of incorporating tailored and personalized exercise programs that align with individual health profiles and conditions, ranging from geriatric care to senior athletes. We also review the benefits that multicomponent exercise interventions, that combine power‐oriented resistance training with high‐intensity interval training, have for improving health outcomes in older adults. Overcoming the barriers that deter older adults from exercising requires a comprehensive approach that addresses psychological, economic, social, environmental, and gender perspective factors to increase participation. Governments play a key role by applying evidence‐based strategies, offering accessible exercise programs, creating supportive environments, and promoting policies that strengthen older adults' motivation and autonomy. These measures should ensure that all older adults have the same opportunities to engage in exercise, ultimately fostering healthier societies.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Consensus document on frailty: conceptualization, detection, multidisciplinary management and future roadmap

  • Álvarez Bustos, Alejandro
  • Andrés-Lacueva, Cristina
  • Ara, Ignacio
  • Arévalo, María Ángeles
  • Bolaños, Juan P.
  • Coto-Montes, Ana
  • Enríquez, José Antonio
  • Escames, Germaine
  • García García, Francisco José
  • Gómez Cabrera, Mari Carmen
  • Grau-Rivera, Oriol
  • Izquierdo Redín, Mikel
  • Martínez Velilla, Nicolás
  • Matheu, Ander
  • Menéndez Colino, Rocío
  • Muñoz Torres, Manuel
  • Nogués, Xavier
  • Oliva Moreno, Juan
  • Orts-Cortés, María Isabel
  • Párraga Martínez, Ignacio
  • Priego, Feliciano
  • Rabassa-Bonet, Montserrat
  • Rol, María Ángeles
  • Serra-Rexach, José Antonio
  • Tarazona-Santabalbina, Francisco José
  • Rodríguez Mañas, Leocadio
  • Abizanda, Pedro
  • CIBERFES Working Group
Background: The lack of a universally accepted definition, a gold-standard assessment tool, and sufficient evidence-based interventions has hindered the integration of frailty into routine clinical practice, particularly outside geriatric medicine. For clinicians, health professionals, policymakers, and aging researchers, a unified framework based on robust evidence has become essential. Objectives: To provide a consensus on relevant aspects of frailty, including definition, attributes, misunderstandings, pathophysiology, phenotypes, assessment, biomarkers, management, stigmas and future challenges, useful for epidemiological, clinical and research application across Europe. Design: Consensus document. Setting: 25 research centers on frailty and healthy aging. Measurements: Relevant aspects on frailty. Results: In this document we present a consensus regarding what frailty is, what frailty is not, what is aging, which are the most common misunderstandings related to frailty, which is the pathophysiology and which are the biomarkers of frailty, how should frailty be assessed and who should assess frailty, how should frailty be managed, the presence or absence of frailty subphenotypes or subtypes, how is the stigma of been considered frail, which are the gender considerations, and which are the current challenges and future directions. We support that frailty is the expression of an age-associated clinical phenotypic syndrome driven by the biology of aging, life-course environmental exposures, and disease burden. Its physiological basis lies in a heterogeneous decline of functional reserve across organ systems, accompanied by impaired homeostasis and reduced capacity to respond to stressors, ultimately predisposing to adverse health outcomes, mainly disability. Conclusions: We present a consensus document on frailty, useful for epidemiological, clinical and research application across Europe., The present study received funding from the projects CB16/10/00408, CB16/10/00269, CB16/10/00477, CB16/10/00383, CB16/10/00282, CB16/10/00289, CB16/10/00238, CB16/10/00456, CB16/10/00435, CB16/10/00417, CB16/10/00315, CB16/10/00496, CB16/10/00468, CB16/10/00475, CB16/10/00245, CB23/10/00037, CB16/10/00501, CB16/10/00464, CB16/10/00239, CB16/10/00314, Instituto de Salud Carlos III, Madrid, Spain.